Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4-week, Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Assess the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel for the Relief of Signs and Symptoms in Patients With Knee Osteoarthritis

NCT01967550 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01967550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01967550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4-week, Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Assess the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel for the Relief of Signs and Symptoms in Patients With Knee Osteoarthritis
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
May 31, 2014
Enrollment
304 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee